Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Notably, prolonged treatment with SM or exenatide over seven days did not result in self-tolerance to anti-allodynia or cross-tolerance to morphine or -endorphin [72]
Important Information This product is a medicine
Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, et al